Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 84601-84650 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT05502770
Development of IVF/ICSI Children Born From Different Endometrial Preparation Protocols
N/A
Recruiting
700 participants
Started: Aug 12, 2022 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT05738408
Remote Smoking Cessation in Hospitalized Cardiac Patients
NA
Recruiting
50 participants
Started: Aug 12, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05227326
AOH1996 for the Treatment of Refractory Solid Tumors
PHASE1
Recruiting
92 participants
Started: Aug 12, 2022 · Completed: Sep 13, 2029
7 conditions
2 sponsors
2 locations
NCT05357651
A Study to Assess the Safety and Efficacy of LB1410 in Participants With Advanced Solid Tumor or Lymphoma(Keyplus-001)
PHASE1
Recruiting
100 participants
Started: Aug 12, 2022 · Completed: Dec 30, 2028
2 conditions
1 sponsor
1 location
NCT04574518
Teachable Moment to Opt-out of Tobacco: Interactive Voice Response Quit Line for Veteran Active Smokers With Lung Nodules
NA
Active, not recruiting
223 participants
Started: Aug 12, 2022 · Completed: Sep 30, 2025
3 conditions
3 sponsors
3 locations
NCT05524883
Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-251 in Participants With Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping
PHASE1/PHASE2
Active, not recruiting
86 participants
Started: Aug 12, 2022 · Completed: Nov 30, 2029
1 condition
1 sponsor
30 locations
NCT06217588
LCAT (Lecithin Cholesterol Acyl Transferase) Natural History Study
N/A
Recruiting
40 participants
Started: Aug 12, 2022 · Completed: Aug 31, 2028
1 condition
1 sponsor
1 location
NCT05494632
Interaural Frequency and Loudness Mismatch in SSD CI Users
NA
Active, not recruiting
45 participants
Started: Aug 12, 2022 · Completed: Aug 1, 2025
1 condition
2 sponsors
1 location
NCT05593107
68Ga-N188 PET/CT Imaging in Malignancy
NA
Recruiting
203 participants
Started: Aug 12, 2022 · Completed: Jul 31, 2025
1 condition
1 sponsor
1 location
NCT05344209
Efficacy and Safety of Anti-PD-1/PD-L1 Treatment +/- UV1 Vaccination in Patients With Non-small Cell Lung Cancer
PHASE2
Recruiting
138 participants
Started: Aug 12, 2022 · Completed: Jul 1, 2027
3 conditions
11 sponsors
1 location
NCT05421663
A Study of JNJ-90014496 in Participants With B-Cell Non-Hodgkin Lymphoma
PHASE1/PHASE2
Recruiting
385 participants
Started: Aug 12, 2022 · Completed: Dec 29, 2028
3 conditions
1 sponsor
30 locations
NCT05104723
Safety and Efficacy of Tofacitinib for Chronic Granulomatous Disease With Inflammatory Complications
PHASE1/PHASE2
Enrolling by invitation
20 participants
Started: Aug 12, 2022 · Completed: Jan 1, 2027
4 conditions
1 sponsor
1 location
NCT06353490
The Clinical Performance Validation of Electronic Thermometer and Infrared Thermometers
NA
Active, not recruiting
150 participants
Started: Aug 12, 2022 · Completed: Aug 11, 2024
2 conditions
1 sponsor
2 locations
NCT05826457
North American Prodromal Synucleinopathy Consortium Stage 2
N/A
Recruiting
500 participants
Started: Aug 12, 2022 · Completed: May 1, 2025
6 conditions
12 sponsors
9 locations
NCT05383287
Characteristics, Phenotypes, and TRAITS of Heart Failure With Preserved Ejection Fraction (TRAITS-HFpEF)
N/A
Recruiting
1,250 participants
Started: Aug 12, 2022 · Completed: Oct 31, 2029
1 condition
1 sponsor
1 location
NCT04875884
Optimized MRI of Patients With Hip Arthroplasty
NA
Recruiting
22 participants
Started: Aug 11, 2022 · Completed: Dec 30, 2027
1 condition
3 sponsors
1 location
NCT05327257
iTBS rTMS in Mild Cognitive Impairment
NA
Active, not recruiting
25 participants
Started: Aug 11, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05050903
Early Antiviral Responses to Rhinovirus Infection in Asthma
N/A
Recruiting
40 participants
Started: Aug 11, 2022 · Completed: Aug 31, 2025
1 condition
1 sponsor
1 location
NCT05339074
Maintenance Ketamine Infusions for Treatment-Resistant Bipolar Depression
PHASE2
Recruiting
60 participants
Started: Aug 11, 2022 · Completed: Feb 28, 2026
4 conditions
1 sponsor
3 locations
NCT05194111
Treating Heart Dysfunction Related to Cancer Therapy With Sacubitril/Valsartan
PHASE1/PHASE2
Recruiting
53 participants
Started: Aug 11, 2022 · Completed: Nov 30, 2026
2 conditions
1 sponsor
1 location
NCT05061134
A Study of Ceralasertib Monotherapy and Ceralasertib Plus Durvalumab in Patients With Melanoma and Resistance to PD-(L)1 Inhibition
PHASE2
Active, not recruiting
194 participants
Started: Aug 11, 2022 · Completed: Nov 2, 2026
1 condition
1 sponsor
66 locations
NCT05480735
EffectiveNess of a Multimodal preHAbilitation Program in patieNts With Bladder canCEr Undergoing Cystectomy
NA
Recruiting
154 participants
Started: Aug 11, 2022 · Completed: Oct 31, 2025
1 condition
9 sponsors
8 locations
NCT05078970
Advancing Suicide Intervention Strategies for Teens During High Risk Periods
NA
Recruiting
306 participants
Started: Aug 11, 2022 · Completed: Aug 1, 2026
4 conditions
2 sponsors
2 locations
NCT05327465
Exercise to Enhance Cardiovascular Health Among Black Prostate Cancer Patients With Androgen Deprivation Therapy
NA
Recruiting
62 participants
Started: Aug 11, 2022 · Completed: Jun 30, 2026
3 conditions
3 sponsors
1 location
NCT05232916
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
PHASE3
Recruiting
750 participants
Started: Aug 11, 2022 · Completed: Dec 31, 2026
1 condition
1 sponsor
161 locations
NCT05392946
Iberdomide, Daratumumab, Bortezomib, and Dexamethasone for Treatment of Newly Diagnosed Multiple Myeloma, IDEAL Study
PHASE1/PHASE2
Active, not recruiting
49 participants
Started: Aug 11, 2022 · Completed: May 31, 2028
1 condition
1 sponsor
1 location
NCT05111574
Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery
PHASE2
Recruiting
99 participants
Started: Aug 11, 2022 · Completed: Dec 19, 2025
17 conditions
1 sponsor
146 locations
NCT05700825
Rehabilitation of Airway Protection in Parkinson's Disease
PHASE2
Recruiting
120 participants
Started: Aug 11, 2022 · Completed: Sep 1, 2027
2 conditions
3 sponsors
2 locations
NCT05007821
Linezolid Dosing Strategies in Drug-Resistant TB
PHASE2
Active, not recruiting
138 participants
Started: Aug 11, 2022 · Completed: Mar 13, 2026
3 conditions
1 sponsor
13 locations
NCT05299008
The Effect of Bethanechol on Tracheobronchomalacia
N/A
Recruiting
20 participants
Started: Aug 11, 2022 · Completed: Jun 30, 2024
1 condition
1 sponsor
1 location
NCT05611502
Influence of TMS on Attention Modulation
NA
Recruiting
40 participants
Started: Aug 11, 2022 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT05439889
Follow-up Study on Chronic Myeloid Leukemia Patients Achieving Treatment-free Remission
N/A
Recruiting
100 participants
Started: Aug 11, 2022 · Completed: Aug 11, 2032
1 condition
1 sponsor
1 location
NCT05368298
SCOOT: Sample Collection for DART
N/A
Recruiting
5,000 participants
Started: Aug 11, 2022 · Completed: Dec 31, 2025
1 condition
8 sponsors
10 locations
NCT05580445
Safety, Pharmacokinetics and Efficacy of CT-707, Toripalimab and Gemcitabine in Advanced Pancreatic Cancer
PHASE1/PHASE2
Recruiting
114 participants
Started: Aug 11, 2022 · Completed: Aug 11, 2024
1 condition
1 sponsor
1 location
NCT05258396
Exploring Cortical Remyelination in Children With Multiple Sclerosis
NA
Recruiting
40 participants
Started: Aug 11, 2022 · Completed: Sep 11, 2025
1 condition
1 sponsor
3 locations
NCT05470348
A Study of BL-B01D1 in Patients With Unresectable Locally Advanced or Metastatic Breast Cancer and Other Solid Tumors
PHASE1
Recruiting
36 participants
Started: Aug 11, 2022 · Completed: Dec 31, 2027
2 conditions
3 sponsors
2 locations
NCT05198323
A Study to Evaluate the Safety and Efficacy of LT3001 Drug Product in Subjects AIS Undergoing EVT
PHASE2
Recruiting
66 participants
Started: Aug 11, 2022 · Completed: Mar 31, 2026
1 condition
1 sponsor
2 locations
NCT05509725
Efficacy and Safety of a Probiotic Formulation in Adults With Irritable Bowel Syndrome With Diarrhea (IBS-D)
PHASE4
Recruiting
162 participants
Started: Aug 11, 2022 · Completed: Nov 30, 2024
1 condition
1 sponsor
1 location
NCT05266222
Respiratory Virus Sampling and Repository
N/A
Recruiting
20,000 participants
Started: Aug 11, 2022 · Completed: Dec 31, 2031
2 conditions
1 sponsor
2 locations
NCT05466708
Safety and Efficacy of Esketamine Combined With Dexmedetomidine for Sedation of Mechanically Ventilated Patients
PHASE4
Recruiting
100 participants
Started: Aug 11, 2022 · Completed: Dec 1, 2024
5 conditions
1 sponsor
1 location
NCT05431270
Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 MAb, Administered Alone and in Combination with a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)
PHASE1/PHASE2
Recruiting
40 participants
Started: Aug 11, 2022 · Completed: Aug 31, 2028
2 conditions
2 sponsors
6 locations
NCT06310954
Ketogenic Diet in Pediatric Intractable Epilepsy
NA
Recruiting
59 participants
Started: Aug 11, 2022 · Completed: Apr 30, 2024
2 conditions
1 sponsor
1 location
NCT05468697
A Study of Belzutifan (MK-6482) in Combination With Palbociclib Versus Belzutifan Monotherapy in Participants With Advanced Renal Cell Carcinoma (MK-6482-024/LITESPARK-024)
PHASE1/PHASE2
Active, not recruiting
210 participants
Started: Aug 10, 2022 · Completed: Jul 21, 2026
1 condition
1 sponsor
13 locations
NCT06548893
Acceptance and Commitment Therapy (ACT) in Groups for Obsessive Compulsive Disorder: A Clinical Trial in Brazil
NA
Active, not recruiting
24 participants
Started: Aug 10, 2022 · Completed: Jun 20, 2026
1 condition
1 sponsor
1 location
NCT04834388
Studying Anakinra to Reduce Secondary Brain Damage After Spontaneous Haemorrhagic Stroke
PHASE2
Recruiting
75 participants
Started: Aug 10, 2022 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT05410054
Quantitative Prognostic Analysis of Upper Limb Motor Dysfunction After Stroke
N/A
Not yet recruiting
178 participants
Started: Aug 10, 2022 · Completed: Dec 31, 2025
5 conditions
1 sponsor
0 locations
NCT05305482
DCS Versus DES for One-month DAPT in Patients With ACS: ONE-PASS Trial
NA
Recruiting
3,520 participants
Started: Aug 10, 2022 · Completed: Feb 14, 2030
1 condition
1 sponsor
1 location
NCT05569382
Treatment Effects of Bisoprolol and Verapamil in Symptomatic Patients With Non-obstructive Hypertrophic Cardiomyopathy
PHASE4
Recruiting
100 participants
Started: Aug 10, 2022 · Completed: Dec 31, 2027
1 condition
4 sponsors
4 locations
NCT05127616
EPPIC: Easing Pelvic Pain Interventions Clinical Research Program
NA
Recruiting
240 participants
Started: Aug 10, 2022 · Completed: May 31, 2026
7 conditions
3 sponsors
3 locations
NCT05522738
Safety and Efficacy of Fruquintinib+FOLFIRI in RAS-mutated Metastatic Colorectal Cancer
PHASE1/PHASE2
Recruiting
46 participants
Started: Aug 10, 2022 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
Previous
1
More pages
1690
1691
1692
1693
1694
1695
1696
More pages
2369
Next